| pubmed-article:10458299 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10458299 | lifeskim:mentions | umls-concept:C0003451 | lld:lifeskim |
| pubmed-article:10458299 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:10458299 | lifeskim:mentions | umls-concept:C0599779 | lld:lifeskim |
| pubmed-article:10458299 | lifeskim:mentions | umls-concept:C0035333 | lld:lifeskim |
| pubmed-article:10458299 | lifeskim:mentions | umls-concept:C0023828 | lld:lifeskim |
| pubmed-article:10458299 | lifeskim:mentions | umls-concept:C0011209 | lld:lifeskim |
| pubmed-article:10458299 | lifeskim:mentions | umls-concept:C0019340 | lld:lifeskim |
| pubmed-article:10458299 | lifeskim:mentions | umls-concept:C0767952 | lld:lifeskim |
| pubmed-article:10458299 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:10458299 | pubmed:dateCreated | 1999-9-21 | lld:pubmed |
| pubmed-article:10458299 | pubmed:abstractText | To evaluate the clinical treatment efficacy of a long-lasting intravitreous injectable anti-cytomegalovirus (CMV) liposomal drug, 1-O-octadecyl-sn-glycerol-3-phosphonoformate (ODG-PFA). | lld:pubmed |
| pubmed-article:10458299 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10458299 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10458299 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10458299 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10458299 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10458299 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10458299 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10458299 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10458299 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10458299 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10458299 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10458299 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10458299 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10458299 | pubmed:issn | 0275-004X | lld:pubmed |
| pubmed-article:10458299 | pubmed:author | pubmed-author:ChengLL | lld:pubmed |
| pubmed-article:10458299 | pubmed:author | pubmed-author:HostetlerK... | lld:pubmed |
| pubmed-article:10458299 | pubmed:author | pubmed-author:FreemanW RWR | lld:pubmed |
| pubmed-article:10458299 | pubmed:author | pubmed-author:MuellerA JAJ | lld:pubmed |
| pubmed-article:10458299 | pubmed:author | pubmed-author:GardnerM FMF | lld:pubmed |
| pubmed-article:10458299 | pubmed:author | pubmed-author:Bergeron-Lynn... | lld:pubmed |
| pubmed-article:10458299 | pubmed:author | pubmed-author:OzerdemUU | lld:pubmed |
| pubmed-article:10458299 | pubmed:author | pubmed-author:SeversonG MGM | lld:pubmed |
| pubmed-article:10458299 | pubmed:author | pubmed-author:Chaidhawangul... | lld:pubmed |
| pubmed-article:10458299 | pubmed:author | pubmed-author:Mach-HofacreB... | lld:pubmed |
| pubmed-article:10458299 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10458299 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:10458299 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10458299 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10458299 | pubmed:pagination | 325-31 | lld:pubmed |
| pubmed-article:10458299 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:10458299 | pubmed:meshHeading | pubmed-meshheading:10458299... | lld:pubmed |
| pubmed-article:10458299 | pubmed:meshHeading | pubmed-meshheading:10458299... | lld:pubmed |
| pubmed-article:10458299 | pubmed:meshHeading | pubmed-meshheading:10458299... | lld:pubmed |
| pubmed-article:10458299 | pubmed:meshHeading | pubmed-meshheading:10458299... | lld:pubmed |
| pubmed-article:10458299 | pubmed:meshHeading | pubmed-meshheading:10458299... | lld:pubmed |
| pubmed-article:10458299 | pubmed:meshHeading | pubmed-meshheading:10458299... | lld:pubmed |
| pubmed-article:10458299 | pubmed:meshHeading | pubmed-meshheading:10458299... | lld:pubmed |
| pubmed-article:10458299 | pubmed:meshHeading | pubmed-meshheading:10458299... | lld:pubmed |
| pubmed-article:10458299 | pubmed:meshHeading | pubmed-meshheading:10458299... | lld:pubmed |
| pubmed-article:10458299 | pubmed:meshHeading | pubmed-meshheading:10458299... | lld:pubmed |
| pubmed-article:10458299 | pubmed:meshHeading | pubmed-meshheading:10458299... | lld:pubmed |
| pubmed-article:10458299 | pubmed:meshHeading | pubmed-meshheading:10458299... | lld:pubmed |
| pubmed-article:10458299 | pubmed:meshHeading | pubmed-meshheading:10458299... | lld:pubmed |
| pubmed-article:10458299 | pubmed:meshHeading | pubmed-meshheading:10458299... | lld:pubmed |
| pubmed-article:10458299 | pubmed:meshHeading | pubmed-meshheading:10458299... | lld:pubmed |
| pubmed-article:10458299 | pubmed:meshHeading | pubmed-meshheading:10458299... | lld:pubmed |
| pubmed-article:10458299 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10458299 | pubmed:articleTitle | Treatment of herpes retinitis in an animal model with a sustained delivery antiviral drug, liposomal 1-O-octadecyl-SN-glycerol-3-phosphonoformate. | lld:pubmed |
| pubmed-article:10458299 | pubmed:affiliation | Shiley Eye Center, University of California-San Diego, La Jolla 92093-0946, USA. | lld:pubmed |
| pubmed-article:10458299 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10458299 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:10458299 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10458299 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10458299 | lld:pubmed |
